Investing in public graphene stocks - Page 2

Solidion Technology, an advanced silicon anode and battery technology materials provider, has announced its operational and financial results for the third quarter of 2024. The Company declared a $4.2 million loss from continuing operations, including increased spending on third-party validation testing for automakers. Net Loss was $6,636,679. 

Solidion Technology also mentioned technological and business developments. Among the technological advancements were: developing and securing a newly granted U.S. patent for technology enabling 5-minute charging of lithium batteries across all climates by leveraging a graphene-based heat spreader for optimal battery temperature control, expanding the Company's industry-leading intellectual property portfolio 1 with 20 new U.S. patents granted this year and achieving third-party validation for the Company's cost-effective process that eliminates the need for toxic silane gas and CVD techniques. 

Sparc Technologies has secured AUD$1.12 million (around USD$730,000) in an R&D tax refund, under the Australian Government's R&D Tax Incentive, relating to the 2024 financial year. 

It was stated that this financial boost comes as a recognition of Sparc’s commitment to advancing sustainable technologies in high-performance coatings and polymers. This refund will strengthen the company’s cash position thereby providing continued support for Sparc's investment in Sparc Hydrogen, ecosparc® field trials and its work developing graphene based additives for high performance coatings and polymers

Volt Carbon Technologies, in collaboration with Downsview Aerospace Innovation & Research (DAIR), has announced that both Volt Carbon's southern Ontario-based mineral processing operation (Toronto) and its subsidiary, Solid UltraBattery (Guelph), have been selected as recipients of the DAIR Green Fund.

The funded projects include: 1) "Development of High-Performance Carbon Materials for Aerospace Industries" and 2) "Advancements in Low-Temperature Performance of Lithium-Ion Batteries." These initiatives aim to advance battery solutions for unmanned aerial systems and enhance the capabilities of graphite and graphene in aerospace materials.

The Victorian government’s AUD$1 million (around USD$650,000) Made In Victoria Energy Technologies Manufacturing program will be awarded to four Victorian businesses manufacturing renewable energy technology components and products. 

Aming recipients is graphene technologies company EnGy, which will use its grant to scale up graphene materials production.

Lyten has announced that it is acquiring manufacturing assets from Northvolt, a Swedish battery manufacturer facing financial difficulties.

Northvolt is selling manufacturing equipment the company inherited in its 2021 acquisition of Cuberg, another battery startup. Lyten will also assume the lease of Cuberg’s old manufacturing facility in San Leandro, California. Lyten will invest $20 million next year to expand facilities in San Leandro and its existing operations in San Jose.

Graphene Manufacturing Group (GMG) has provided an update detailing its strengthened working capital and significant cost reductions.

The Company received AUD$2.85 million (around USD$1,840,000) under Australia’s R&D Tax Incentive program, raising its cash balance to AUD$5.56 million (about USD$3,600,000) as of November 1, with no outstanding debt or loan facilities. Australia’s R&D Tax Incentive continues to be a major support mechanism for GMG, covering 43.5% of eligible R&D expenses each year. This funding has proven vital in advancing GMG's research and development, particularly for projects in energy savings and energy storage.

Today we published a new edition of our Graphene Investment Guide, with all the latest information and financial updates from public graphene companies. This is still a challenging time for many graphene companies - and also for graphene investors, but we are seeing signs of increased activity and improved conditions in the graphene industry, which will hopefully contribute to public graphene companies.

It is a time of consolidation in the industry - and investors should be careful when looking at early stage graphene companies. Most graphene companies struggle to generate meaningful revenues, and we expect consolidation and liquidation to continue in the next few years.

The Graphene Investment Guide includes:

• An introduction to graphene
• An overview of graphene's most exciting applications
• An analysis of graphene's potential
• Market forecasts from leading analysts
• Detailed descriptions and financials of all public graphene companies
• Over 80 financial reports and company presentations (premium edition only)
• Graphene-Info's own investment thesis and action plan

Any technology-driven investor that wishes to stay current on the most promising new nanotechnology should look into this report. The report includes extensive data and information needed to launch a successful strategic graphene investment portfolio.

NanoXplore has reported its first quarter 2025 financial results. 

The Company revenue was CA$33.7 million (around US$24,220,000), up 16% from 1Q 2024. Net loss was CA$2.72 million (around US$1,950,000) - loss narrowed by 27% from 1Q 2024. The Company expects total revenues of between CA$140 million (over US$100,600,000) and CA$155 million (around US$111,400,000) for the year ending June 30, 2025.

Zentek has announced that its wholly-owned subsidiary Triera Biosciences has received a CAD$1.1 million (around USD$791,000) Government of Canada contract to test its multivalent aptamer technology for the rapid drug discovery of therapeutics or prophylactics of highly pathogenic avian influenza (“HPAI”) A(H5N1).

Triera was awarded a these funds through Innovation, Science and Economic Development Canada's (“ISED”) Innovative Solutions Canada (“ISC”) program: Health Advanced And Emerging Medical Technologies. Triera’s multivalent aptamer technology was selected for its potential to be used as a rapid drug development platform.

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, has announced the closing of a $50 million Series B financing round. The round was led by imec.xpand with new investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa. Existing investors Asabys Partners, Aliath Bioventures and Vsquared also participated, bringing the total amount raised since inception to $68 million.

In addition to the Series B round, INBRAIN also secured additional funding and support from Merck KGaA to advance the clinical development of its technology in Merck’s therapeutic areas of interest. This partnership will boost the translation of INBRAIN’s platform to human use, expanding its impact across both central and peripheral nervous system applications.